SNDX Syndax Pharmaceuticals, Inc.
Healthcare$19.98+0.00%OpenMarket Cap: $1.77B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$41.50
Target (Median)
$41.50
Target Range
$37.00 - $46.00
Upside from current price: 107.7%
Rating Distribution
2 Strong Buy11 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-22 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-05-13 | UBS | maintain | Buy | Buy |
| 2026-05-01 | Barclays | maintain | Overweight | Overweight |
| 2026-04-01 | Goldman Sachs | maintain | Buy | Buy |
| 2026-03-31 | Mizuho | maintain | Outperform | Outperform |
| 2026-03-09 | JP Morgan | maintain | Overweight | Overweight |
| 2026-03-02 | Citigroup | maintain | Buy | Buy |
| 2026-01-27 | Mizuho | maintain | Outperform | Outperform |
| 2025-12-09 | BTIG | maintain | Buy | Buy |
| 2025-11-24 | Barclays | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.59 | $509.8M | 9 |
| Sun Dec 31 | $0.65 | $693.4M | 8 |
| Mon Dec 31 | $2.20 | $907.7M | 6 |
| Tue Dec 31 | $3.12 | $1.10B | 6 |